Blood Clots and Near-Stroke Motivated Survivor to Launch Atrial Fibrillation Month in September to Focus on Arrhythmia That Causes Stroke
This September, StopAfib.org marks the third year of celebrating Atrial Fibrillation Month to raise awareness of atrial fibrillation (afib), a common cause of stroke.
StopAfib.org founder, Mellanie True Hills, knows the toll that atrial fibrillation takes on those with it and their families. After surviving blood clots and a near-stroke during her first afib episode, she lived in constant fear of her next, always wondering if a deadly stroke was inevitable. As a patient who was unable to stabilize on Coumadin® (warfarin), a challenging blood thinner that helps avoid strokes, she was frightened that she was "a stroke walking around waiting to happen."
Once she was cured surgically of this common cardiac arrhythmia, she couldn't stand on the sidelines and watch others suffer so she started StopAfib.org, for patients by patients. StopAfib.org helps those living the nightmare of atrial fibrillation.
Since afib frequently isn't diagnosed until after a stroke, or two, and identifying the problem can be a multi-year process, she has a sense of urgency around raising awareness of atrial fibrillation that only an afib survivor can possess.
Learn more about Atrial Fibrillation Month and living with afib at:
September 2009 is Atrial Fibrillation Month: StopAfib.org patient resource raises awareness of expensive and life-threatening irregular heartbeat
Please help us with Afib Month in the following ways:
- Contact Us to alert us to any special Afib Month events so we can post them to the Atrial Fibrillation Month Events Calendar
- Tell others about afib and where to learn more
We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add a CommentComments
There are no comments yet. Be the first one and get the conversation started!